This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated GABARAP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GABARAP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~13.9 kDa | |
| Gel | 12–15% | |
| Negative control | siRNA / KO lysate |
| PTM | Cleaved | |
| Caveat | Lipidation alters mobility | |
| Regulation | IFN-γ-induced | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for GABARAP — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human HEK293 , Lane 2: human Jurkat , Lane 3: human A549 , Lane 4: human HELA , Lane 5: human U87 , Lane 6: human HEPG2 , Lane 7: human U937 , Lane 8: rat liver , Lane 9: rat pancreas , Lane 10: mouse liver , Lane 11: mouse pancreas . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-GABARAP antigen affinity purified polyclonal antibody (Catalog # A01907-2) at 0.25 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for GABARAP at approximately 18KD. The expected band size for GABARAP is at 18KD |
| Gel % | 12–15% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.25 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 18 kDa |
GABARAP's 13.9 kDa predicted mass should appear as a near-identical ~14 kDa band, with only a minor shift expected from C-terminal propeptide processing to the mature form.
| single band near 13-14 kDa | matches the predicted mass of unmodified, non-glycosylated 117-aa GABARAP with no disulfide-linked modification |
| band running just below the mass of the 117-aa full-length sequence | C-terminal propeptide cleavage at residue 117 generates the mature, processed form of GABARAP |
| closely spaced doublet near 14 kDa | co-occurrence of the uncleaved precursor and the propeptide-processed mature GABARAP species |
| band present across most whole-cell lysate lanes tested | cytoplasmic and membrane/vesicle-associated localization (autophagosome, Golgi, endomembrane) means GABARAP is retained intracellularly rather than secreted, so it is detectable directly in lysate |
| higher-molecular-weight band or smear above the monomer under mild denaturation | incomplete dissociation of GABARAP from interaction partners such as ATG7, ATG13, ATG3, GPHN, or NSF |
| no extra bands beyond the single species or doublet | only one isoform is annotated for GABARAP, so additional bands are not expected from alternative splicing |
| predicted mass (13.9 kDa, 117 aa) | sets the baseline expected migration position near 13-14 kDa for the unmodified protein |
| C-terminal propeptide cleavage (residue 117) | removes the terminal propeptide to yield the mature form, giving a band marginally smaller than the full 117-aa precursor |
| single annotated isoform (no alternative splicing) | no isoform-derived bands are expected; any extra bands point to processing state or degradation rather than splice variants |
| membrane/vesicle-associated subcellular pool (autophagosome, Golgi, endomembrane, cytoskeleton) | partitioning into membrane and cytoskeletal fractions means incomplete lysis or solubilization can weaken apparent band intensity without changing its size |
| interactions with ATG7, ATG13, ATG3, GPHN, and NSF | under incomplete denaturation these complexes can co-migrate, producing higher-molecular-weight bands above the monomer |
| Situation | Likely cause | Next action |
|---|---|---|
| Band lower than expected | C-terminal propeptide cleavage removes the terminal residue to generate the mature, slightly smaller GABARAP species | confirm the antibody epitope location relative to the processed C-terminus and compare migration against a full-length recombinant standard |
| Band higher than expected | incomplete denaturation leaves GABARAP complexed with interacting partners such as ATG7, ATG13, ATG3, GPHN, or NSF | boil samples longer in fresh reducing SDS sample buffer to fully dissociate protein complexes before loading |
| Broad smear instead of sharp band | the small ~14 kDa size of GABARAP is poorly resolved on standard low-percentage gels | run a higher-percentage or gradient gel (e.g. 12-15% or 5-20%) to sharpen resolution of this low-molecular-weight protein |
| Multiple bands | co-existence of the uncleaved 117-aa precursor with the propeptide-processed mature form produces a closely spaced doublet | extend run time or use a higher-resolution low-MW gel system to separate the doublet and identify which species the antibody detects |
| Weak or no signal | small proteins like GABARAP can transfer through the membrane during blotting, or membrane/cytoskeleton-associated pools can be under-extracted | shorten transfer time or reduce voltage, use a 0.2 micron membrane, and use a lysis buffer that solubilizes membrane and cytoskeletal fractions |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for GABARAP, answered from its protein features.
BosterBio's GABARAP antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-GABARAP antibody is a best-performing, extensively cited reagent, rigorously validated by orthogonal methods including negative-tissue controls and complementary techniques, ensuring specific, reproducible detection in Western blot applications.
Which to pick: Only one Boster GABARAP antibody is catalogued, A01907-2; it includes an actual Western blot validation image, so it's the clear choice for GABARAP WB experiments.